Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double-blind clinical study
DOI:
https://doi.org/10.2340/0001555564354357Abstract
The clinical effect on acne vulgaris of topical treatment with meclocycline sulfosalicylate and systemic treatment with peroral tetracycline (500 mg daily) was compared in a double-blind study of 60 patients treated for 8 weeks. The reducing effect of Meclosorb cream and tetracycline tablets on the number of closed comedones, pustules, papules and cysts was marked and not significantly different. The effect of Meclosorb on open comedones was weak and of slow onset. No side effects were registered. Topical treatment with Meclosorb is an effective and safe alternative to systemic tetracycline treatment of acne vulgaris.Downloads
Download data is not yet available.
Downloads
Published
1984-07-01
How to Cite
Hjorth, N., Schmidt, H., Thomsen, K., & Dela, K. (1984). Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double-blind clinical study. Acta Dermato-Venereologica, 64(4), 354–357. https://doi.org/10.2340/0001555564354357
Issue
Section
Articles
License
LicenseAll digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
